Prevalensi Resistensi ARV Lini Pertama pada Pasien yang Menerima Pengobatan Haart di Klinik HIV RSUP Sanglah Bali Tahun 2014 - 2016

  • Jessica Santosa Program Studi Profesi Dokter, Fakultas Kedokteran Universitas Udayana
  • I Made Susila Utama Bagian/SMF Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Udayana/RSUP Sanglah

Abstract

HIV is a virus that weakens the immune system. HIV can be classified into two genotypes, namely HIV-1 and HIV-2. Genotyping of
HIV-1 can be classified into three groups: group M, N, and O. Therapy for patients with positive HIV today is HAART or Highly Active
Antiretroviral Therapy at present has much-experienced resistance to first-line. This study is an observational study with a crosssectional
study to determine the prevalence of resistance to first-line ARV therapy. The research was conducted from September
2014 until January 2016 at the HIV clinic Sanglah Hospital. The data collection is done with a short interview and filling the
questionnaire, as well as secondary data from medical records of patients. Of the 68 samples that follow this study, 9 (13.2%) of
whom experienced resistance and undergoing treatment with second-line antiretroviral drugs.

Downloads

Download data is not yet available.

Author Biographies

Jessica Santosa, Program Studi Profesi Dokter, Fakultas Kedokteran Universitas Udayana

Program Studi Profesi Dokter, Fakultas Kedokteran Universitas Udayana

I Made Susila Utama, Bagian/SMF Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Udayana/RSUP Sanglah

Bagian/SMF Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Udayana/RSUP Sanglah

Published
2017-10-02
How to Cite
SANTOSA, Jessica; SUSILA UTAMA, I Made. Prevalensi Resistensi ARV Lini Pertama pada Pasien yang Menerima Pengobatan Haart di Klinik HIV RSUP Sanglah Bali Tahun 2014 - 2016. E-Jurnal Medika Udayana, [S.l.], v. 6, n. 10, p. 42 - 44, oct. 2017. ISSN 2303-1395. Available at: <https://ojs.unud.ac.id/index.php/eum/article/view/34590>. Date accessed: 22 nov. 2024.